Free Trial

Will the Biotech sector sustain its momentum in 2024?

Key Points

  • Biotech's iShares ETF (IBB) experienced a near 4% upswing on the year's first trading day, outshining struggling sectors.
  • The IBB ETF now faces critical resistance at $138 after a robust three-month climb.
  • AMGN, VRTX, and GILD, the top holdings in the ETF, significantly impact the sector's direction based on their individual performances.
  • 5 stocks we like better than iShares Biotechnology ETF

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should you invest $1,000 in iShares Biotechnology ETF right now?

Before you consider iShares Biotechnology ETF, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iShares Biotechnology ETF wasn't on the list.

While iShares Biotechnology ETF currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Ryan Hasson
About The Author

Ryan Hasson

Contributing Author

Technical Analysis, Momentum Trading, Risk Management

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Amgen (AMGN)
4.4984 of 5 stars
4.50 / 5 stars
$334.85+0.2%2.69%47.84Moderate Buy$312.63
Gilead Sciences (GILD)
4.757 of 5 stars
4.76 / 5 stars
$77.01+0.7%4.00%213.92Hold$81.81
Vertex Pharmaceuticals (VRTX)
3.8672 of 5 stars
3.87 / 5 stars
$495.26+0.6%N/A32.14Moderate Buy$460.30
iShares Biotechnology ETF (IBB)N/A$148.26+0.8%0.27%N/AN/AN/A
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

What Does a ’Buy’ Rating Mean for Investors?
Tesla Stock Dip: A Buyer’s Alert
Robotics Stock Rockets on NVIDIA Investment

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines